🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label study will evaluate EMB-001, comprised of metyrapone, a cor...
Status
Unknown
Location
Rose Research Center
Start Date
2021-05-19
Trial ID
NCT04868253
Treatments Being Tested
The purpose of this study is to test whether metyrapone is an effective and...
Status
Completed
Location
Dept. of Psychiatry and Psychotherapy, UKE
Start Date
1998-05
Trial ID
NCT00125554
Treatments Being Tested
A study to investigate the effects GSK561679 on part of the body's system t...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-06
Trial ID
NCT00426608
Treatments Being Tested
This is a study of EMB-001 (a combination of two FDA-approved drugs, metyra...
Status
Completed
Location
Collaborative Neuroscience Network, LLC
Start Date
2018-03-01
Trial ID
NCT03404817
Treatments Being Tested
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Terminated
Location
Embera Site
Start Date
2021-06-10
Trial ID
NCT04933916
Treatments Being Tested
In a randomized, cross-over study, 20 healthy volunteers will receive a blo...
Status
Completed
Location
University Hospital Basel
Start Date
2022-02-08
Trial ID
NCT05167084
EMB-001 is a combination of 2 drugs: the cortisol synthesis inhibitor, mety...
Status
Completed
Location
Vince & Associates
Start Date
2016-07
Trial ID
NCT02856854
Treatments Being Tested